Bladex (NYSE: BLX) sells US$200 million AT1 notes with 7.50% coupon
Rhea-AI Filing Summary
Banco Latinoamericano de Comercio Exterior, S.A. (Bladex) has priced its inaugural Additional Tier 1 (AT1) capital offering in international markets, raising US$200 million through perpetual, non-cumulative instruments with an initial call date after seven years. The AT1 notes carry a 7.50% coupon and were more than three times oversubscribed, indicating strong interest from a broad base of global institutional investors.
The bank describes this as a landmark debut of a hybrid capital instrument, intended to optimize its capital structure under local rules and the Basel III framework. Bladex plans to use the proceeds to further strengthen its capital base, support future loan growth, and keep capitalization comfortably above regulatory requirements, while also broadening access to global capital markets and enhancing financial flexibility.
Positive
- Raised US$200 million in inaugural AT1 issuance, adding Basel III-compliant hybrid capital to strengthen Bladex’s regulatory capital base and support future loan growth.
- Strong demand and pricing: the AT1 notes, carrying a 7.50% coupon and seven-year first call, were more than three times oversubscribed by global institutional investors.
Negative
- None.
Insights
Bladex boosts capital with US$200 million inaugural AT1 issue.
Bladex has issued US$200 million of perpetual, non-cumulative Additional Tier 1 (AT1) instruments, priced at a 7.50% coupon with an initial call after seven years. As a Basel III-compliant hybrid security, AT1 typically counts toward regulatory capital, helping the bank reinforce its loss-absorbing buffer without issuing common equity.
The deal was more than three times oversubscribed, with demand from a diversified group of global institutional investors, which suggests solid market appetite for the bank’s credit risk at this yield. Management states that proceeds will support future loan growth while maintaining capitalization above regulatory minimums, implying room to expand the balance sheet within current rules.
Over time, investors can track how this new layer of capital interacts with Bladex’s stated objective to keep “robust capital and liquidity metrics” as it prudently grows its loan portfolio. Any future disclosures on capital ratios and funding costs will help quantify the longer-term impact of the US$200 million AT1 issuance on profitability and resilience.
AI-generated analysis. How Rhea-AI works. Not financial advice.
